Larocop 20 mg/ml Suspension for injection

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

Copper methionate

Available from:

Chanelle Pharmaceuticals Manufacturing Limited

ATC code:

QA12CX

INN (International Name):

Copper methionate

Dosage:

20 milligram(s)/millilitre

Pharmaceutical form:

Suspension for injection

Prescription type:

LR: Licensed Retailer as defined in national legislation

Therapeutic group:

Cattle, Sheep

Therapeutic area:

Other mineral products

Therapeutic indications:

Vitamins and minerals

Authorization status:

Authorised

Authorization date:

1991-10-01

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Larocop 20 mg/ml Suspension for injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Copper (as copper methionate)
20 mg/ml
EXCIPIENT(S):
Chlorocresol (as preservative)
1 mg/ml
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
A sterile blue suspension for injection.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle and sheep.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the prevention and treatment of copper deficiency in cattle and
sheep and clinical conditions associated with copper
deficiency.
4.3 CONTRAINDICATIONS
Not to be administered by the intravenous route.
Do not use in animals with known hypersensitivity to the active
ingredient.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
The copper status of animals should be checked pre-treatment. This is
particularly important in sheep where overdose
can lead to haemolytic crisis.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_0_
_3_
_/_
_0_
_1_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_4_
_2_
_0_
_6_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
The likelihood of a nodule appearing can be reduced by the use of the
proper injection technique.
Shake the vial vigorously to re-suspend the solid prior to use.
Inject into a clean site only in the neck area by deep intramuscular
injection.
Avoid injection